Nilufer P. Seth

1.8k total citations
24 papers, 1.3k citations indexed

About

Nilufer P. Seth is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Nilufer P. Seth has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Nilufer P. Seth's work include Immune Cell Function and Interaction (15 papers), T-cell and B-cell Immunology (13 papers) and Immunotherapy and Immune Responses (6 papers). Nilufer P. Seth is often cited by papers focused on Immune Cell Function and Interaction (15 papers), T-cell and B-cell Immunology (13 papers) and Immunotherapy and Immune Responses (6 papers). Nilufer P. Seth collaborates with scholars based in United States, United Kingdom and Germany. Nilufer P. Seth's co-authors include Kai W. Wucherpfennig, Laurent Gauthier, Heiner Appel, Paul Klenerman, Michaela Lucas, Zbigniew M. Szczepiorkowski, Cheryl L. Day, Georg M. Lauer, Bruce D. Walker and Gregory K. Robbins and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and The EMBO Journal.

In The Last Decade

Nilufer P. Seth

24 papers receiving 1.2k citations

Peers

Nilufer P. Seth
J. A. Frelinger United States
H Yagita Japan
Judie Boisvert United States
Sian Llewellyn‐Lacey United Kingdom
Xiao-Song He United States
David J. Kittlesen United States
J. A. Frelinger United States
Nilufer P. Seth
Citations per year, relative to Nilufer P. Seth Nilufer P. Seth (= 1×) peers J. A. Frelinger

Countries citing papers authored by Nilufer P. Seth

Since Specialization
Citations

This map shows the geographic impact of Nilufer P. Seth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nilufer P. Seth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nilufer P. Seth more than expected).

Fields of papers citing papers by Nilufer P. Seth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nilufer P. Seth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nilufer P. Seth. The network helps show where Nilufer P. Seth may publish in the future.

Co-authorship network of co-authors of Nilufer P. Seth

This figure shows the co-authorship network connecting the top 25 collaborators of Nilufer P. Seth. A scholar is included among the top collaborators of Nilufer P. Seth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nilufer P. Seth. Nilufer P. Seth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benson, Micah J., David von Schack, Sean Keegan, et al.. (2014). Modeling the Clinical Phenotype of BTK Inhibition in the Mature Murine Immune System. The Journal of Immunology. 193(1). 185–197. 19 indexed citations
2.
Zhong, Xiaotian, Nilufer P. Seth, Z. Sean Juo, et al.. (2012). Engineering novel Lec1 glycosylation mutants in CHO–DUKX cells: Molecular insights and effector modulation of N‐acetylglucosaminyltransferase I. Biotechnology and Bioengineering. 109(7). 1723–1734. 23 indexed citations
3.
Nickerson‐Nutter, Cheryl, Lioudmila Tchistiakova, Nilufer P. Seth, et al.. (2011). Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys. Lara D. Veeken. 50(6). 1033–1044. 6 indexed citations
4.
Yi, Woelsung, et al.. (2010). Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence. Journal of Clinical Investigation. 120(4). 1324–1336. 57 indexed citations
5.
Call, Melissa, Monika‐Sarah E. D. Schulze, Kevin Fowler, et al.. (2010). HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide. Nature Immunology. 12(1). 54–61. 80 indexed citations
6.
Call, Melissa, Xuechao Xing, Gregory D. Cuny, et al.. (2009). In Vivo Enhancement of Peptide Display by MHC Class II Molecules with Small Molecule Catalysts of Peptide Exchange. The Journal of Immunology. 182(10). 6342–6352. 28 indexed citations
7.
Perone, Marcelo J., Suzanne Bertera, William J. Shufesky, et al.. (2009). Suppression of Autoimmune Diabetes by Soluble Galectin-1. The Journal of Immunology. 182(5). 2641–2653. 80 indexed citations
8.
Bowen, David G., Naglaa H. Shoukry, Arash Grakoui, et al.. (2008). Variable Patterns of Programmed Death-1 Expression on Fully Functional Memory T Cells after Spontaneous Resolution of Hepatitis C Virus Infection. Journal of Virology. 82(10). 5109–5114. 34 indexed citations
9.
Varma, Ashok K., Rebecca A. Buonpane, Penny Zhu, et al.. (2007). Structural basis of T‐cell specificity and activation by the bacterial superantigen TSST‐1. The EMBO Journal. 26(4). 1187–1197. 47 indexed citations
11.
Ulsenheimer, Axel, Michaela Lucas, Nilufer P. Seth, et al.. (2006). Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T‐cell responses. Journal of Viral Hepatitis. 13(10). 708–714. 25 indexed citations
12.
Moradi, Babak, Nilufer P. Seth, Xuechao Xing, et al.. (2006). Small Molecules That Enhance the Catalytic Efficiency of HLA-DM. The Journal of Immunology. 176(7). 4208–4220. 44 indexed citations
13.
Haining, W. Nicholas, Sascha Ansén, Zhinan Xia, et al.. (2005). Gene Expression Profiling Identifies BAX-δ as a Novel Tumor Antigen in Acute Lymphoblastic Leukemia. Cancer Research. 65(21). 10050–10058. 28 indexed citations
14.
Tian, Chaorui, Jessamyn Bagley, Nathalie Cretin, et al.. (2004). Prevention of type 1 diabetes by gene therapy. Journal of Clinical Investigation. 114(7). 969–978. 69 indexed citations
15.
Haining, W. Nicholas, John Evans, Nilufer P. Seth, et al.. (2004). Measuring T cell immunity to influenza vaccination in children after haemopoietic stem cell transplantation. British Journal of Haematology. 127(3). 322–325. 27 indexed citations
16.
Tian, Chaorui, Jessamyn Bagley, Nathalie Cretin, et al.. (2004). Prevention of type 1 diabetes by gene therapy. Journal of Clinical Investigation. 114(7). 969–978. 6 indexed citations
17.
Day, Cheryl L., Nilufer P. Seth, Michaela Lucas, et al.. (2003). Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. Journal of Clinical Investigation. 112(6). 831–842. 222 indexed citations
18.
Seth, Nilufer P., et al.. (2003). Ex Vivo Analysis of Thymic CD4 T Cells in Nonobese Diabetic Mice with Tetramers Generated from I-Ag7/Class II-Associated Invariant Chain Peptide Precursors. The Journal of Immunology. 171(8). 4175–4186. 44 indexed citations
19.
Day, Cheryl L., Nilufer P. Seth, Michaela Lucas, et al.. (2003). Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. Journal of Clinical Investigation. 112(6). 831–842. 216 indexed citations
20.
Appel, Heiner, Nilufer P. Seth, Laurent Gauthier, & Kai W. Wucherpfennig. (2001). Anergy Induction by Dimeric TCR Ligands. The Journal of Immunology. 166(8). 5279–5285. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026